Edition:
United Kingdom

vTv Therapeutics Inc (VTVT.OQ)

VTVT.OQ on NASDAQ Stock Exchange Global Market

6.85USD
23 Feb 2018
Change (% chg)

$0.00 (+0.00%)
Prev Close
$6.85
Open
$6.88
Day's High
$7.01
Day's Low
$6.62
Volume
24,521
Avg. Vol
49,355
52-wk High
$8.37
52-wk Low
$3.63

Revenue & Earnings Per Share

    Revenue* Earnings Per Share**
FY 2017 Jun '17 0.01 -0.409
Mar '17 0.03 -0.435
FY 2016 Dec '16 0.04 -0.418
Sep '16 0.04 -0.412
Jun '16 0.18 -0.466
Mar '16 0.38 -0.417
 
*Note: Units in Millions ofU.S. Dollars
**Note: Units in U.S. Dollars

Consensus Estimates Analysis

  # of Estimates Mean High Low 1 Year Ago
SALES (in millions)
Quarter Ending Mar-18 2 5.00 10.00 0.00 --
Quarter Ending Jun-18 1 0.00 0.00 0.00 --
Year Ending Dec-18 4 11.25 30.00 0.00 0.22
Earnings (per share)
Quarter Ending Mar-18 1 -0.44 -0.44 -0.44 --
Quarter Ending Jun-18 1 -0.45 -0.45 -0.45 --
Year Ending Dec-18 4 -1.54 -1.09 -1.89 -2.29
Sales and Profit Figures in US Dollar (USD);

Valuation Ratios

  Company industry sector
P/E Ratio (TTM) -- 83.93 32.90
P/E High - Last 5 Yrs. -- 292.71 45.97
P/E Low - Last 5 Yrs. -- 91.44 24.37
Beta -- 0.90 0.89
Price to Sales (TTM) 1,715.07 110.72 5.77
Price to Book (MRQ) -- 13.56 5.41
Price to Tangible Book (MRQ) -- 14.02 6.98
Price to Cash Flow (TTM) -- 71.33 23.42
% Owned Institutions 43.52 12.89 2.22

Dividends

  Company industry sector
Dividend Yield -- 0.31 1.50
Dividend Yield - 5 Year Avg -- 0.26 1.52
Dividend 5 Year Growth Rate -- 1.66 5.21
Payout Ratio(TTM) -- 15.70 43.73

Growth Rates

  Company industry sector
Sales (MRQ) vs Qtr. 1 Yr. Ago -92.86 398.34 9.24
Sales (TTM) vs TTM 1 Yr. Ago -87.02 78.63 5.59
Sales - 5 Yr. Growth Rate -- 32.11 10.27
EPS (MRQ) vs Qtr. 1 Yr. Ago 12.26 25.10 19.66
EPS (TTM) vs TTM 1 Yr. Ago 2.83 -- --
EPS - 5 Yr. Growth Rate -- 38.95 10.73
Capital Spending - 5 Yr. Growth Rate -- 40.24 15.19

Financial Strength

  Company industry sector
Quick Ratio (MRQ) -- 1.80 2.18
Current Ratio (MRQ) 2.95 5.30 2.97
LT Debt to Equity (MRQ) -- 22.82 12.22
Total Debt to Equity (MRQ) -- 24.47 16.52
Interest Coverage (TTM) -184.51 -98.78 33.13

Profitability Ratios

  Company industry sector
Gross Margin (TTM) -- 40.03 54.70
Gross Margin - 5 Yr. Avg. -- 51.06 52.42
EBITD Margin (TTM) -44,528.57 -- --
EBITD - 5 Yr. Avg -- -572.68 10.86
Operating Margin (TTM) -44,714.29 -717.10 4.64
Operating Margin - 5 Yr. Avg. -- -594.00 6.26
Pre-Tax Margin (TTM) -46,147.90 -691.66 5.44
Pre-Tax Margin - 5 Yr. Avg. -- -597.35 6.60
Net Profit Margin (TTM) -46,147.90 -692.88 1.76
Net Profit Margin - 5 Yr. Avg. -- -600.21 2.91
Effective Tax Rate (TTM) -- 22.57 23.04
Effective Tax Rate - 5 Yr. Avg. -- 18.19 23.96

Efficiency

  Company industry sector
Revenue/Employee (TTM) 2,333 22,602,130 855,673,508
Net Income/Employee (TTM) -1,076,784 2,968,748 100,656,226
Receivable Turnover (TTM) -- 20.14 5.78
Inventory Turnover (TTM) -- 2.36 3.35
Asset Turnover (TTM) 0.00 0.39 0.93

Management Effectiveness

  Company industry sector
Return on Assets (TTM) -107.09 -1.05 10.98
Return on Assets - 5 Yr. Avg. -- -0.57 12.37
Return on Investment (TTM) -134.79 1.66 14.43
Return on Investment - 5 Yr. Avg. -- 2.23 16.18
Return on Equity (TTM) -- 2.58 16.13
Return on Equity - 5 Yr. Avg. -- 3.13 17.47
  1 Year 3 Year 5 Year
Sales % 22.16 -13.39 --
EPS (TTM) % 48.44 -- --
Dividend % -- -- --
Note: Units in Millions of US Dollars

Performance for vTv Therapeutics Inc

Note:: Rank is a percentile that ranges from 0 to 99, with 99 = best.

Institutional Holders

% Shares Owned: 41.35%
# of Holders: 68
Total Shares Held: 4,008,156
3 Mo. Net Change: 20,045
# New Positions: 9
# Closed Positions: 5
# Increased Positions: 28
# Reduced Positions: 21
# Net Buyers: 7
NYSE and AMEX quotes delayed by at least 20 minutes. NASDAQ delayed by at least 15 minutes. For a complete list of exchanges and delays, please click here.